A single dose polyanhydride-based vaccine platform promotes and maintains anti-GnRH antibody titers.
Schaut RG, Brewer MT, Hostetter JM, Mendoza K, Vela-Ramirez JE, Kelly SM, Jackman JK, Dell'Anna G, Howard JM, Narasimhan B, Zhou W, Jones DE.
Schaut RG, et al. Among authors: jones de.
Vaccine. 2018 Feb 8;36(7):1016-1023. doi: 10.1016/j.vaccine.2017.12.050.
Vaccine. 2018.
PMID: 29413092